Cardiovascular and Circulatory System Congestive Heart Failure

Table of Contents

RECENT HIGHLIGHTS AND CHANGES
--Recent Highlights and Changes
UPCOMING PATENT EXPIRES BY THERAPY AREA
Congestive Heart Failure Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects

--Top Companies in late stage Congestive Heart Failure Projects
--Amylin Pharmaceuticals Inc
--Amgen Inc
--Biogen Idec Inc
--Baxter International Inc
--CardioPep Pharma GmbH
--Bristol-Myers Squibb Company
--Debiopharm Group
--Curacyte AG
--Genfit
--Forest Laboratories Inc
--Menarini Group
--Mediolanum farmaceutici S.p.A.
--Orion Corporation
--Merck & Co Inc
--Sanofi-Aventis
--Protemix Corporation Limited
--Solvay S.A.
--Sigma-Tau S.p.A.
--Zealand Pharma A/S
--Speedel

--Top Companies in early stage Congestive Heart Failure Projects
--Angion Biomedica Corp.
--Amgen Inc
--Azevan Pharmaceuticals, Inc.
--Asklepios BioPharmaceutical Inc.
--Corimmun GmbH
--Celladon Corporation
--Cytopia
--CV Therapeutics Inc
--NanoCor Therapeutics, Inc.
--HRA Pharma
--NOXXON Pharma AG
--Novavax Inc
--Sanofi-Aventis
--Palatin Technologies Inc
--Teijin Pharma Limited
--Targeted Genetics Corp
--Unigene Laboratories Inc
--Theregen, Inc.
--Warren Pharmaceuticals, Inc.
--VasoGenix Pharmaceuticals, Inc.

Pipeline Revenue
--Pipeline Revenue
Full Pipeline View
--Pre Clinical Pipeline View
--Phase I Pipeline View
--Phase II Pipeline View
--Phase III Pipeline View
--Pending Approval Pipeline View
--On the Market Pipeline View
--Discovery/Development Pipeline View